Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATNEC - Axillary Management in T1-3N1M0 Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases at Presentation After Neoadjuvant Chemotherapy

NCT04109079 is registered in ClinicalTrials.gov with University Hospitals of Derby and Burton NHS Foundation Trust as lead sponsor.

NCT NCT04109079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04109079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATNEC - Axillary Management in T1-3N1M0 Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases at Presentation After Neoadjuvant Chemotherapy
Lead sponsor
University Hospitals of Derby and Burton NHS Foundation Trust
Phase
Not applicable
Overall status
Recruiting
Start date
February 26, 2021
Completion date
February 28, 2030
Enrollment
1,900 (estimated)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neoplasm, breast, sentinel lymph node